Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
Clinical trial NCT00340080 · COMPLETED
Trial details
- NCT number
- NCT00340080
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Enrollment
- 1806
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.